The present invention relates to substituted pyrimidines useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.
本发明涉及作为HIF脯氨酰羟化酶抑制剂用于治疗贫血和类似病症的取代嘧啶。
ZOBOVA N. N.; LITVINOV I. A.; NAUMOV V. A.; SAGITOVA R. N., DOKL. AN CCCP, 292,(1987) N 6, 1384-1387
作者:ZOBOVA N. N.、 LITVINOV I. A.、 NAUMOV V. A.、 SAGITOVA R. N.
DOI:——
日期:——
HAXAP S.; TISHCHENKO I . G.; BUBEL O. N.; BIBA V. I., XIMIYA GETEROTSIKL. SOED.,(1987) N 7, 985-988
作者:HAXAP S.、 TISHCHENKO I . G.、 BUBEL O. N.、 BIBA V. I.
DOI:——
日期:——
Relative conjugative abilities of three-membered-ring heterocycles with benzene based on carbon-13 and nitrogen-15 NMR
作者:DeLanson R. Crist、Guy J. Jordan、Donald W. Moore、Joseph A. Hashmall、Arnold P. Borsetti、Saleh A. Turujman
DOI:10.1021/ja00351a002
日期:1983.6
Synthesis of a New Water-Soluble <i>C</i><sub>2</sub>-Symmetric Chiral Diamine: Preliminary Investigation of Its Catalytic Properties for Asymmetric Hydrogenation under Biphasic Conditions
introduction of phosphonic acid moieties on the para position of the aromatic rings. Preliminary investigation of the catalytic properties of the iridium complex of this ligand under biphasic conditions showed that this system compared well with the homogeneous counterpart for the asymmetric hydrogenation of ketones but with noticeably higher reaction rates for the biphasic system.